BioRestorative Therapies, Inc. (BRTX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 10.61M |
| Enterprise Value | 9.1M |
| P/E Ratio | -0.07 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 6.25 |
| Price/Book Ratio | 0.47 |
| Enterprise/Revenue | -2.35 |
| Enterprise/EBITDA | 0.08 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -30.9 |
| Operating Margin | -39.75 |
AD
Management Effectiveness
| Return On Assets | -2.38 |
| Return On Equity | -4.24 |
Income Statement
| Revenue | 359,700 |
| Revenue/Share | 0.4 |
| Gross Profit | 335,856 |
| EBITDA | -14.03M |
| Net Income | -14.24M |
| Diluted EPS | -31.6 |
Balance Sheet
| Total Cash | 3.59M |
| Total Cash/Share | 4.05 |
| Total Debt | 34,515 |
| Total Debt/Equity | 0.01 |
| Current Ratio | 2.35 |
| Book Value Per Share | 3.41 |
Price History
| 52-Week Change | -94.87 |
| 52-Week High | 34 |
| 52-Week Low | 1.28 |
| Moving Average 50 Days | 2.85 |
| Moving Average 200 Days | 6.95 |
Statistics
| Average Volume | 27,222 |
| Shares Outstanding | 1.38M |
| % Held by Institutions | 29.64 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | -0 |
| Last Split Factor | 1:20 |
| Last Split Date | September 08, 2026 |
AD
